David A. Siegel Revolution Medicines, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 30,866 shares of RVMD stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,866

Previous 46,022 32.93%

Holding current value

$1.74 Million

Previous $1.79 Million 21.72%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $559,559 - $726,578	-15,156 Reduced 32.93%	30,866 $1.4 Million
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $179,905 - $242,818	-5,969 Reduced 11.48%	46,022 $1.79 Million
Q1 2024 May 15, 2024	SELL	$26.56 - $33.55 $366,528 - $462,989	-13,800 Reduced 20.98%	51,991 $1.68 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $232,879 - $433,016	12,691 Added 23.9%	65,791 $1.89 Million
Q3 2023 Nov 14, 2023	SELL	$25.17 - $35.05 $571,359 - $795,634	-22,700 Reduced 29.95%	53,100 $1.47 Million
Q2 2023 Aug 14, 2023	SELL	$20.28 - $27.0 $2.03 Million - $2.7 Million	-99,900 Reduced 56.86%	75,800 $2.03 Million
Q1 2023 May 15, 2023	SELL	$20.76 - $30.09 $80,964 - $117,351	-3,900 Reduced 2.17%	175,700 $3.81 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $189,176 - $273,171	-10,700 Reduced 5.62%	179,600 $4.28 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $1.45 Million - $2.16 Million	83,100 Added 77.52%	190,300 $3.75 Million
Q2 2022 Aug 15, 2022	SELL	$14.54 - $27.17 $331,512 - $619,476	-22,800 Reduced 17.54%	107,200 $2.09 Million
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $770,295 - $1.17 Million	44,500 Added 52.05%	130,000 $3.32 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $477,260 - $660,520	19,600 Added 29.74%	85,500 $2.15 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $1.35 Million - $1.88 Million	56,200 Added 579.38%	65,900 $1.81 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $145,000 - $237,200	5,000 Added 106.38%	9,700 $308,000
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $174,887 - $255,821	4,700 New	4,700 $216,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.95B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account